Global Kidney Stone Market Size Likely to Surpass at a CAGR of 3.7% By 2033

As per the current market research conducted by the CMI Team, the global Kidney Stone Market size is expected to record a CAGR of 3.7% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 3,335.5 Million. By 2033, the valuation is anticipated to reach USD 4,625.6 million.

Kidney Stone Market: Growth Factors and Dynamics

• Increasing Prevalence and Incidence Rates: The kidney stone market is driven by the rising prevalence and incidence rates of kidney stone disease globally. Factors such as dietary habits, sedentary lifestyles, obesity, and dehydration contribute to the growing burden of kidney stone disease, thereby fueling market growth.

• Technological Advancements in Treatment Modalities: Advances in minimally invasive surgical techniques, such as shock wave lithotripsy (SWL), ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL), have significantly improved treatment outcomes and patient experiences. The adoption of innovative medical devices and equipment for kidney stone management drives market expansion.

• Growing Geriatric Population: The aging population is more susceptible to kidney stone formation due to age-related physiological changes and comorbidities. As the global population continues to age, the prevalence of kidney stone disease among older adults rises, contributing to market growth as healthcare providers seek effective management solutions.

• Rising Demand for Non-invasive Treatment Options: Patients increasingly prefer non-invasive or minimally invasive treatment options for kidney stone management to avoid surgical complications and reduce recovery times. This trend drives the demand for procedures like SWL and URS, spurring innovation and competition among market players.

• Increased Awareness and Education: Growing awareness campaigns and educational initiatives about kidney stone prevention, risk factors, and treatment options have empowered patients to seek timely medical intervention. Enhanced patient education and awareness efforts contribute to early diagnosis, prompt treatment, and better management of kidney stone disease, fostering market growth.

• Expanding Healthcare Infrastructure and Access to Treatment: Improvements in healthcare infrastructure, particularly in emerging economies, facilitate greater access to diagnostic facilities and treatment modalities for kidney stone disease. Increased healthcare expenditure, coupled with government initiatives to improve healthcare access and affordability, supports market expansion by addressing unmet medical needs and reducing treatment disparities.

• Investments in Healthcare Infrastructure: Governments and healthcare providers may invest in expanding healthcare infrastructure and improving access to kidney stone treatment facilities to address the backlog of postponed procedures and meet the growing demand for kidney stone management. Investments in healthcare infrastructure are crucial for supporting market recovery and ensuring timely access to kidney stone treatments.

Kidney Stone Market: Partnership and Acquisitions

• In 2022, Calyxo secured USD 32 million in funding for its vacuum-assisted device designed to remove kidney stone fragments. This investment underscores confidence in Calyxo’s innovative solution, signaling potential advancements in kidney stone treatment and strengthening its position in the market.

• In 2021, Boston Scientific Corporation’s acquisition of Lumenis Ltd. for USD 1.07 billion includes its global surgical business, specializing in energy-based medical solutions. This strategic move enables Boston Scientific to utilize Lumenis Ltd.’s innovative MOSES technology, facilitating business expansion and diversification.

Report Scope

Kidney Stone Market: COVID-19 Analysis

The COVID-19 pandemic has had a significant impact on the Kidney Stone Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Disruption in Healthcare Services: During the COVID-19 pandemic, many healthcare facilities diverted resources and prioritized resources towards managing COVID-19 patients, leading to a reduction in elective procedures, including kidney stone treatments. This resulted in a decrease in the number of kidney stone procedures performed, affecting market demand for related medical devices and treatments.

• Delayed Diagnosis and Treatment: Due to lockdowns, travel restrictions, and fear of exposure to the virus, many individuals delayed seeking medical care for kidney stone symptoms. This delay in diagnosis and treatment could potentially lead to an increase in the severity of kidney stone-related complications, impacting the demand for kidney stone management products and services.

• Resumption of Elective Surgeries: With the easing of pandemic restrictions and the rollout of vaccination programs, healthcare facilities are gradually resuming elective procedures, including kidney stone treatments. This resumption of services is expected to drive demand for kidney stone management products and services.

• Telemedicine and Remote Consultations: The adoption of telemedicine and remote consultations surged during the pandemic, allowing patients to receive medical advice and consultations remotely. Post-COVID-19, telemedicine may continue to play a significant role in kidney stone management, offering convenience and accessibility to patients, and thereby supporting market recovery.

• Rising Demand for Non-invasive Treatment Options: Patients may show a preference for non-invasive or minimally invasive treatment options for kidney stones, such as shock wave lithotripsy (SWL) and ureteroscopy (URS), which involve shorter hospital stays and faster recovery times. The demand for these procedures is expected to increase post-pandemic, driving market recovery.

• Focus on Public Health Awareness: Increased public health awareness campaigns about kidney stone prevention, symptoms, and treatment options may encourage individuals to seek timely medical care, leading to early diagnosis and treatment. Enhanced awareness efforts can contribute to market recovery by addressing delayed diagnoses and reducing the severity of kidney stone-related complications.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Kidney Stone Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Kidney Stone Market:

• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical Inc.
• DirexGroup
• R. Bard Inc.
• Dornier MedTech GmbH
• Siemens Healthineers AG
• Stryker Corporation
• Richard Wolf GmbH
• Karl Storz SE & Co. KG
• Allengers Medical Systems Limited
• EMS Electro Medical Systems S.A.
• Medispec Ltd.
• Convergent Laser Technologies
• Elmed Electronics & Medical Industry & Trade Inc.
• Others

The Kidney Stone Market is segmented as follows:

Type of Treatment

• Extracorporeal Shock Wave Lithotripsy (ESWL)
• Ureteroscopy (URS)
• Percutaneous Nephrolithotomy (PCNL)
• Others

By Type of Kidney Stone

• Calcium Stones
• Struvite Stones
• Uric Acid Stones
• Cystine Stones
• Others

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America